Canopy Growth (WEED) Receives Buy Rating from Benchmark
Canopy Growth (TSE:WEED)‘s stock had its “buy” rating reiterated by equities research analysts at Benchmark in a research report issued on Tuesday. They presently have a C$100.00 price target on the stock. Benchmark’s target price suggests a potential upside of 47.84% from the stock’s current price.
WEED has been the topic of several other reports. Cowen upped their price target on shares of Canopy Growth from C$56.00 to C$74.00 in a research note on Tuesday, September 4th. Eight Capital upped their price target on shares of Canopy Growth from C$40.00 to C$50.00 in a research note on Friday, July 6th. Cormark upped their price target on shares of Canopy Growth from C$33.00 to C$40.00 in a research note on Thursday, August 16th. Finally, Canaccord Genuity upgraded shares of Canopy Growth from a “hold” rating to a “speculative buy” rating and upped their price target for the company from C$34.00 to C$50.00 in a research note on Thursday, August 16th.
WEED stock opened at C$67.64 on Tuesday. Canopy Growth has a 52 week low of C$10.61 and a 52 week high of C$74.45.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.
Featured Article: What strategies should day traders use to execute a trade?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.